# Nuo Therapeutics, Inc.: Form 8-K, filed Feb 1, 2017

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 8-K
- Filed: 2017-02-01
- Accepted by EDGAR: Feb 1, 2017, 17:17 ET
- Period: 2017-01-31
- Accession: 0001437749-17-001471
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774917001471/nuot20170131_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774917001471/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774917001471/nuot20170131_8k.htm

Filed Feb 1, 2017.
Source: SEC EDGAR, the filing index for accession 0001437749-17-001471. Last ingested by Listed: Nov 14, 2026, 23:44 ET. No prices; not investment advice.
